TrialBlood2009

Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.

Farrukh T Awan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.